• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Gene expression profiling of breast cancer.

作者信息

Pusztai Lajos

机构信息

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA.

出版信息

Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S11. doi: 10.1186/bcr2430. Epub 2009 Dec 18.

DOI:10.1186/bcr2430
PMID:20030862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2797691/
Abstract
摘要

相似文献

1
Gene expression profiling of breast cancer.乳腺癌的基因表达谱分析
Breast Cancer Res. 2009;11 Suppl 3(Suppl 3):S11. doi: 10.1186/bcr2430. Epub 2009 Dec 18.
2
Biological basis of breast cancer: an introduction.
Semin Oncol. 2007 Apr;34(2 Suppl 3):S1-3. doi: 10.1053/j.seminoncol.2007.03.018.
3
Comprehensive profiling of biological processes reveals two major prognostic subtypes in breast cancer.生物过程的全面分析揭示了乳腺癌的两种主要预后亚型。
Tumour Biol. 2016 Mar;37(3):3365-70. doi: 10.1007/s13277-015-4173-9. Epub 2015 Oct 7.
4
Interleukin 8 in progression of hormone-dependent early breast cancer.白细胞介素8在激素依赖性早期乳腺癌进展中的作用
J Biosci. 2017 Jun;42(2):265-274. doi: 10.1007/s12038-017-9679-4.
5
AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer.AR 通路活性与 AR 表达呈 HER2 依赖性相关，并且是乳腺癌更好的预后因素。
Cell Oncol (Dordr). 2020 Apr;43(2):321-333. doi: 10.1007/s13402-019-00492-6. Epub 2020 Jan 13.
6
Understanding resistance to tamoxifen in hormone receptor-positive breast cancer.了解激素受体阳性乳腺癌对他莫昔芬的耐药性。
Clin Chem. 2009 Aug;55(8):1453-5. doi: 10.1373/clinchem.2009.125377. Epub 2009 Jun 18.
7
SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.丝氨酸蛋白酶抑制剂A1（SERPINA1）是雌激素受体的直接靶基因，也是乳腺癌患者生存的预测指标。
Oncotarget. 2015 Sep 22;6(28):25815-27. doi: 10.18632/oncotarget.4441.
8
A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions.早期乳腺肿瘤中存在一个共享的转录程序，尽管存在基因和临床差异。
Genome Biol. 2014 May 23;15(5):R71. doi: 10.1186/gb-2014-15-5-r71.
9
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.双模态指数鉴定的黑色素瘤相关抗原家族 A 将三阴性乳腺癌的一个亚组定义为免疫反应增强的候选者。
Eur J Cancer. 2012 Jan;48(1):12-23. doi: 10.1016/j.ejca.2011.06.025. Epub 2011 Jul 7.
10
Is gene array testing to be considered routine now?现在是否应该考虑将基因芯片检测作为常规检测？
Breast. 2011 Oct;20 Suppl 3:S87-91. doi: 10.1016/S0960-9776(11)70301-0.

引用本文的文献

1
Potential clinically useful prognostic biomarkers in triple-negative breast cancer: preliminary results of a retrospective analysis.三阴性乳腺癌中潜在的临床有用预后生物标志物：一项回顾性分析的初步结果
Breast Cancer (Dove Med Press). 2018 Nov 23;10:177-194. doi: 10.2147/BCTT.S175556. eCollection 2018.
2
Prognostic immune-related gene models for breast cancer: a pooled analysis.乳腺癌的预后免疫相关基因模型：一项汇总分析。
Onco Targets Ther. 2017 Sep 11;10:4423-4433. doi: 10.2147/OTT.S144015. eCollection 2017.
3
An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk.一种优化的用于预测激素受体阴性和三阴性乳腺癌转移风险的五基因多平台预测指标。
Breast Cancer Res. 2013;15(5):R103. doi: 10.1186/bcr3567.
4
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.新辅助化疗后残留乳腺癌的分析鉴定出 DUSP4 缺陷是耐药的一种机制。
Nat Med. 2012 Jul;18(7):1052-9. doi: 10.1038/nm.2795.
5
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.FNCLCC-PACS 01 随机试验中，辅助化疗治疗淋巴结阳性乳腺癌的蛋白表达、生存和多西他赛获益。
Breast Cancer Res. 2011;13(6):R109. doi: 10.1186/bcr3051. Epub 2011 Nov 1.
6
Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer.原发性乳腺癌回顾性分析中极染色体不稳定性与长期生存的关系。
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2183-94. doi: 10.1158/1055-9965.EPI-11-0343. Epub 2011 Jul 22.
7
Kinome expression profiling and prognosis of basal breast cancers.基态乳腺癌的激酶组表达谱与预后。
Mol Cancer. 2011 Jul 21;10:86. doi: 10.1186/1476-4598-10-86.
8
Biologic markers determine both the risk and the timing of recurrence in breast cancer.生物标志物可确定乳腺癌的复发风险和复发时间。
Breast Cancer Res Treat. 2011 Sep;129(2):607-16. doi: 10.1007/s10549-011-1564-5. Epub 2011 May 20.
9
Do two machine-learning based prognostic signatures for breast cancer capture the same biological processes?两种基于机器学习的乳腺癌预后标志物是否捕捉到相同的生物学过程？
PLoS One. 2011 Mar 14;6(3):e17795. doi: 10.1371/journal.pone.0017795.
10
Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers.年轻、肿瘤增殖增加和 FOXM1 表达仅预测内分泌依赖性乳腺癌的早期转移性复发。
Breast Cancer Res Treat. 2011 Apr;126(3):803-10. doi: 10.1007/s10549-011-1345-1. Epub 2011 Jan 12.

本文引用的文献

1
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.在NSABP-B 28随机临床试验中评估微管相关蛋白-Tau表达作为预后和预测标志物的情况。
J Clin Oncol. 2009 Sep 10;27(26):4287-92. doi: 10.1200/JCO.2008.21.6887. Epub 2009 Aug 10.
2
Mammary development meets cancer genomics.乳腺发育与癌症基因组学相遇。
Nat Med. 2009 Aug;15(8):842-4. doi: 10.1038/nm0809-842.
3
Genomic grade index is associated with response to chemotherapy in patients with breast cancer.基因组分级指数与乳腺癌患者对化疗的反应相关。
J Clin Oncol. 2009 Jul 1;27(19):3185-91. doi: 10.1200/JCO.2008.18.5934. Epub 2009 Apr 13.
4
Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study.预测伴有前哨淋巴结转移的乳腺癌患者非前哨淋巴结状态的模型比较：一项前瞻性多中心研究。
J Clin Oncol. 2009 Jun 10;27(17):2800-8. doi: 10.1200/JCO.2008.19.7418. Epub 2009 Apr 6.
5
Gene-expression signatures in breast cancer.乳腺癌中的基因表达特征
N Engl J Med. 2009 Feb 19;360(8):790-800. doi: 10.1056/NEJMra0801289.
6
Supervised risk predictor of breast cancer based on intrinsic subtypes.基于内在亚型的乳腺癌监督风险预测器
J Clin Oncol. 2009 Mar 10;27(8):1160-7. doi: 10.1200/JCO.2008.18.1370. Epub 2009 Feb 9.
7
Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.分子疾病亚组对雌激素受体阳性乳腺癌随机辅助化疗试验中无病生存期的影响。
J Clin Oncol. 2008 Oct 1;26(28):4679-83. doi: 10.1200/JCO.2008.17.2544. Epub 2008 Jul 28.
8
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.乳腺癌基因表达谱的荟萃分析：旨在对乳腺癌亚型和预后特征达成统一认识。
Breast Cancer Res. 2008;10(4):R65. doi: 10.1186/bcr2124. Epub 2008 Jul 28.
9
Systematic review: gene expression profiling assays in early-stage breast cancer.系统评价：早期乳腺癌中的基因表达谱分析
Ann Intern Med. 2008 Mar 4;148(5):358-69. doi: 10.7326/0003-4819-148-5-200803040-00208. Epub 2008 Feb 4.
10
Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer.微管相关蛋白tau是雌激素受体阳性乳腺癌内分泌敏感性和化疗耐药性的双功能预测指标。
Clin Cancer Res. 2007 Apr 1;13(7):2061-7. doi: 10.1158/1078-0432.CCR-06-2078.